AGP Executive Report
Last update: 7 hours agoHIV Treatment Milestone in Taiwan: TaiMed Biologics says Trogarzo (ibalizumab) has received a TFDA Drug License Collection Notice, clearing the final regulatory step toward commercial launch for multidrug-resistant HIV-1 patients. Food Safety Accountability: Central Union Oil was fined NT$165.2 million after delayed reporting of benzopyrene-contaminated soybean oil, triggering recalls and penalties across the supply chain. Mosquito-Borne Disease Alert: Taiwan’s CDC warns that El Niño could raise dengue risk, urging people to prevent mosquito bites as temperatures and rainfall patterns shift. Infant Product Safety Push: A DPP lawmaker calls for tighter oversight of baby items sold online, citing risks like choking and unsafe sleep setups from unassessed products. Pharma Manufacturing Expansion: Bora Pharmaceuticals completed its acquisition of MacroGenics’ GMP manufacturing operations, boosting biologics CDMO capacity with a Taiwan development site. Extreme Weather Preparedness: Super Typhoon Bavi is prompting evacuations and disaster readiness planning in the Philippines and could disrupt regional supply chains as it heads toward Taiwan/China. Health Tech & Diagnostics Market Signals: New market reports highlight fast growth in microfluidic devices and lab information systems, reflecting rising demand for diagnostics and lab workflow modernization.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.